...
首页> 外文期刊>Diabetes/metabolism research and reviews >The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea
【24h】

The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea

机译:有效持续气道正压通气对中度至重度阻塞性呼吸暂停非糖尿病患者体内稳态模型评估胰岛素抵抗的影响

获取原文
获取原文并翻译 | 示例

摘要

Previous studies on the effects of continuous positive airway pressure (CPAP) on homeostasis model assessment insulin resistance (HOMA-IR) in obstructive sleep apnea patients have yielded conflicting results. Therefore, we conducted this meta-analysis to evaluate the impact of effective CPAP on HOMA-IR in non-diabetic patients with moderate to severe obstructive sleep apnea. We searched PubMed, HighWire Press, Ovid Medline (R), Cochrane library and EMBASE before December 2011 on original English language studies. The data on HOMA-IR and body mass index (BMI) were extracted from these studies. As compared with baseline values, 8 to 24weeks of effective CPAP (>4hight) treatment significantly reduced HOMA-IR by an average of 0.75(95% CI, from -0.96 to -0.53; p<0.001). However, in subjects with irregular CPAP (<4hight), this effect was not observed (-0.22; 95%CI, from -2.24 to 1.80; p=0.83). There were no intervention-related changes in BMI in both regular and irregular CPAP. Our analysis showed that 8 to 24weeks of effective CPAP could significantly improve HOMA-IR in non-diabetic patients with moderate to severe obstructive sleep apnea, while no significant changes in BMI were detected. Further large scale, randomized and controlled trials are needed to evaluate the longer treatment and its possible effects on weight control and cardiovascular disease.
机译:先前关于持续气道正压通气(CPAP)对阻塞性睡眠呼吸暂停患者体内稳态模型评估胰岛素抵抗(HOMA-IR)的影响的研究得出了相互矛盾的结果。因此,我们进行了这项荟萃分析,以评估有效的CPAP对中度至重度阻塞性睡眠呼吸暂停的非糖尿病患者HOMA-IR的影响。我们在2011年12月之前在PubMed,HighWire Press,Ovid Medline(R),Cochrane图书馆和EMBASE上搜索了原始英语语言研究。从这些研究中提取了HOMA-IR和体重指数(BMI)的数据。与基线值相比,有效CPAP(> 4h /晚)治疗8-24周可显着降低HOMA-IR平均0.75(95%CI,从-0.96降低至-0.53; p <0.001)。但是,在患有不规则CPAP(<4小时/晚)的受试者中,未观察到这种效果(-0.22; 95%CI,从-2.24至1.80; p = 0.83)。常规和非常规CPAP的BMI均无与干预相关的变化。我们的分析表明,在中度至重度阻塞性睡眠呼吸暂停的非糖尿病患者中,有效的CPAP在8至24周内可以显着改善HOMA-IR,而未检测到BMI的显着变化。需要进一步的大规模,随机和对照试验来评估更长的治疗方法及其对体重控制和心血管疾病的可能影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号